ARVINAS

Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. The company was founded in 2013 and is headquartered in Connecticut, United States.

#SimilarOrganizations #People #Financial #Event #Website #More

ARVINAS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2013-01-01

Address:

New Haven, Connecticut, United States

Country:

United States

Website Url:

http://www.arvinas.com

Total Employee:

101+

Status:

Active

Contact:

(203)535-1456

Email Addresses:

[email protected]

Total Funding:

111.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager Domain Not Resolving Nginx Microsoft Exchange Online Office 365 Mail

Similar Organizations

anjarium-biosciences-logo

Anjarium Biosciences

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

cerulean-pharma-logo

Cerulean Pharma

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

icosavax-logo

Icosavax

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

imcyse-logo

Imcyse

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

vasorx-logo

VasoRx

VasoRx is developing RNA therapies for diseases of the cardiovascular system & oncology such as atherosclerosis and pulmonary hypertension.

ventirx-pharmaceuticals-logo

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.

Current Advisors List

timothy-shannon_image

Timothy Shannon Board Chairman @ Arvinas
Board_member

john-houston_image

John Houston Board Member @ Arvinas
Board_member

not_available_image

Ted Kennedy Board Member @ Arvinas
Board_member

thomas-lynch_image

Thomas Lynch Member of the Scientific Advisory Board @ Arvinas
Advisor

colleen-cuffaro_image

Colleen Cuffaro Board Observer @ Arvinas
Board_observer

kush-parmar_image

Kush Parmar Board Member @ Arvinas
Board_member
2013-07-01

liam-ratcliffe_image

Liam Ratcliffe Board Member @ Arvinas
Board_member

jakob-loven_image

Jakob Loven Board Member @ Arvinas
Board_member
2018-03-01

Current Employees Featured

john-houston_image

John Houston
John Houston President and CEO @ Arvinas
President and CEO
2017-01-01

angela-m-cacace_image

Angela M. Cacace
Angela M. Cacace Vice President of Neuroscience and Platform Biology @ Arvinas
Vice President of Neuroscience and Platform Biology
2018-01-01

matthew-batters_image

Matthew Batters
Matthew Batters Vice President @ Arvinas
Vice President
2018-01-01

sean-cassidy_image

Sean Cassidy
Sean Cassidy Chief Financial Officer @ Arvinas
Chief Financial Officer
2014-01-01

andy-crew_image

Andy Crew
Andy Crew Senior Vice President, Chemistry @ Arvinas
Senior Vice President, Chemistry
2013-01-01

craig-m-crews_image

Craig M. Crews
Craig M. Crews Founder @ Arvinas
Founder
2013-07-01

marcia-dougan-moore_image

Marcia Dougan Moore
Marcia Dougan Moore Senior Vice President, Strategic Operations @ Arvinas
Senior Vice President, Strategic Operations
2020-01-01

ron-peck_image

Ron Peck
Ron Peck CMO @ Arvinas
CMO
2019-07-01

ian-taylor_image

Ian Taylor
Ian Taylor CSO @ Arvinas
CSO

not_available_image

Lewis B. Cullman
Lewis B. Cullman Co-Founder @ Arvinas
Co-Founder

Founder

craig-m-crews_image

Craig M. Crews

not_available_image

Lewis B. Cullman

Stock Details

Company's stock symbol is NASDAQ:ARVN

Investors List

orbimed-advisors_image

Investments List

Date	Company	Article	Money raised
2020-02-27	Oerth Bio	Arvinas investment in Corporate Round - Oerth Bio	55 M USD

Key Employee Changes

Date	New article
2022-08-01	Arvinas Appoints John Northcott as Chief Commercial Officer

Official Site Inspections

http://www.arvinas.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.92 K

Host Informations
Whois Informations

Loading ...